Zullo Investment Group, Inc. Geo Vax Labs, Inc. Transaction History

Zullo Investment Group, Inc.

  • $227 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.55 - $17.1 $165 - $5,130
-300 Reduced 35.8%
538 $0
Q3 2022

Nov 08, 2022
BUY
$0.4 - $58.5 $335 - $49,023
838 New
838 $1,000

About GeoVax Labs, Inc.

GOVX Quotes by TradingView
  • Ticker GOVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,744,000
  • Market Cap $51.2M
  • Description
  • GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...
More about GOVX
Track This Portfolio

Track Zullo Investment Group, Inc. Portfolio

Follow Zullo Investment Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zullo Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Zullo Investment Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email